| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 17.79× | 17.79× | 15.07× | 11.59× | 8.89× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2.56× | 2.56× | 2.43× | 2.85× | 2.95× | ||
| 0.61× | 0.61× | 0.62× | 0.63× | 0.62× | ||
| 1.19× | 1.19× | 1.32× | 1.10× | 1.20× | ||
| 0.76× | 0.76× | 0.89× | 0.71× | 0.75× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 8.89 | 11.59 | 15.07 | 17.79 | 17.79 | |
| Working Capital Turnover | 2.95 | 2.85 | 2.43 | 2.56 | 2.56 | |
| Asset Turnover | 0.62 | 0.63 | 0.62 | 0.61 | 0.61 | |
| Cash Conversion (CFO/Net Income) | 1.20 | 1.10 | 1.32 | 1.19 | 1.19 | |
| CFO/EBITDA | 0.75 | 0.71 | 0.89 | 0.76 | 0.76 |